Lawmaker data counted 5,973 gallstone and 1,264 pancreatitis cases after prescriptions. Endocrinologists say rapid weight loss and glucose shifts may explain some.
Recap by typeshit. Full story at Korea Biomedical Review.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
Online sellers pitch peptides for weight loss, anti-aging and muscle gain, and Gavin Coote's full story looks at the risks of products nobody regulates.
The UK firm says it climbed from 3,048th in July on Lilly's supply rankings, with repeat orders now over 30% of revenue and a 14,000-a-day fulfilment line coming.
Times Now reports the study tied GLP-1 use to 25% lower odds of stroke and 49% lower odds of Alzheimer's. The full findings are at the source.
Loading…